We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Medical Devices » Commercial Operations

Commercial Operations
Commercial Operations RSS Feed RSS

Medix Biochemica Deepens IVD Footprint with Acquisition of Bioresource Technology

June 23, 2022
Finland-based Medix Biochemica is strengthening its presence in the in vitro diagnostic (IVD) market with the purchase of Bioresource Technology for an undisclosed sum. Read More

Boston Scientific Grows Stent Pipeline with Majority Stake in Korean Company

June 21, 2022
Boston Scientific will expand its stent manufacturing pipeline by acquiring Synergy Innovation’s majority stock holdings in M.I. Tech, a Korean company that created a family of specialty endoscopic and urologic stents that Boston Scientific has distributed in Japan since 2015. Read More

MPP Signs Licensing Pact with Biotech Africa for COVID-19 Test

June 17, 2022
The Medicines Patent Pool (MPP) has inked a patent-sharing agreement with South African pharmaceutical company Biotech Africa to accelerate the manufacturing and sale of a COVID-19 antibody test. Read More

BD to Expand Medication Management Offerings in $1.5 Billion Parata Systems Purchase

June 7, 2022
Beckton Dickinson (BD) announced the $1.5 billion acquisition of Durham, N.C.-based Parata Systems, a purchase that will give BD access to Parata’s portfolio of pharmacy automation products, such as pouch and blister medication adherence packaging and high-speed robotic dispensing technologies. Read More

Novela Neurotechnologies Acquires Brain Sentinel’s Seizure Devices

June 3, 2022
Novela Neurotechnologies, a digital health company that specializes in epilepsy care, has acquired a portfolio of seizure-monitoring devices through the purchase of Brain Sentinel’s intellectual property, including 58 patents and applications. Read More

Medtronic and DaVita Create New Device Group Focused on Kidney Care

May 31, 2022
Medtronic and DaVita have teamed up to form a new medical device group — provisionally named “NewCo” — that will focus on independent kidney care. Read More

Progenity Sells Its Liquid Biopsy Technologies to Enumera Molecular

May 17, 2022
Progenity will receive an ownership stake in Enumera Molecular. Read More

Medtronic Completes $1.1 Billion Purchase of Implant Maker Intersect ENT

May 16, 2022
Medtronic has completed its $1.1 billion acquisition of the ear, nose and throat (ENT) implant manufacturer Intersect ENT, picking up Intersect’s Propel and Sinuva drug-eluting sinus implant product lines and its Menlo Park, Calif., facility. Read More

MoodSpark Expands Digital Therapy Options with Dthera Sciences Purchase

May 12, 2022
Kansas-based Telememory, doing business as MoodSpark, has acquired Dthera Sciences, gaining the San Diego, Calif. company’s cognitive behavioral therapy (CBT) technology for seniors suffering from confusion or memory loss. Read More

Adaptiiv Teams up with HP and Varian for Cancer Treatments Using 3D Printed Devices

May 12, 2022
Adaptiiv Medical Technologies, a medical device software developer based in Halifax, Nova Scotia, has partnered with the 3D printing giant HP and the radiation oncology firm Varian to offer customized 3D printed devices for use in radiation treatments. Read More

Labcorp Launches Home Diagnostic Test Collection Service with Getlabs

April 28, 2022
Labcorp, one of the nation’s largest diagnostic test companies, has launched an at-home test collection service that combines the company’s diagnostic tests with Getlabs’ at-home phlebotomoy service. Read More

Abbott Makes $3.3B on COVID-19 Tests in First Quarter of 2022

April 26, 2022
Laboratory and molecular diagnostics are already seeing a decline in COVID-19 testing-related sales, the company said. Read More
Previous 1 2 3 4 5 6 7 8 9 … 148 149 Next

Upcoming Events

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 27Jul

    Applying the Lessons of the Pandemic to Your Upcoming Trial

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FX Receives FDA Clearance for Its FX V135 Shoulder Arthroplasty Platform

  • FDA Recommends Modified COVID-19 Vaccine Boosters Adapted to Omicron BA.4 and BA.5 Subvariants

  • FDA Approves Foundation Medicine’s Companion Diagnostic for Genentech’s Rozlytrek

  • Novartis Pays $100 Million for Mallinckrodt’s Priority Review Voucher

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing